Genomtec S.A. (WSE: GMT)
Poland
· Delayed Price · Currency is PLN 7.43
-0.05 (-0.67%)
Nov 21, 2024, 4:46 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 98.34 million as of November 22, 2024. Its market cap has decreased by -27.07% in one year.
Market Cap
98.34M
Enterprise Value
86.83M
Revenue
2.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
7.43
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 98.34M, a decrease of -11.05%. That is a compound annual growth rate of -3.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 22, 2024 | 98.34M | -26.06% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | 110.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krka, d. d. | 18.49B |
| NEUCA S.A. | 3.49B |
| Sopharma AD | 2.12B |
| Synektik Spólka Akcyjna | 1.49B |
| Celon Pharma S.A. | 1.40B |
| Voxel S.A. | 1.28B |
| Ryvu Therapeutics S.A. | 1.00B |
| Selvita S.A. | 982.02M |